Long-term combined therapy with an angiotensin type I receptor blocker and an angiotensin converting enzyme inhibitor prolongs survival in dilated cardiomyopathy.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples